This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Author: Avi Kapoor | May 01, 2025 01:40pm
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Baird analyst Andrew Wittmann downgraded the rating for Parsons Corporation (NYSE:PSN) from Outperform to Neutral and lowered the price target from $72 to $69. Parsons shares closed at $66.86 on Wednesday. See how other analysts view this stock.
Wells Fargo analyst Larry Biegelsen downgraded Glaukos Corporation (NYSE:GKOS) from Overweight to Equal-Weight and lowered the price target from $160 to $86. Glaukos shares closed at $94.25 on Wednesday. See how other analysts view this stock.
Wells Fargo analyst Yanan Zhu downgraded the rating for Regulus Therapeutics Inc. (NASDAQ:RGLS) from Overweight to Equal-Weight and announced a $9 price target. Regulus Therapeutics shares closed at $7.98 on Wednesday. See how other analysts view this stock.
Considering buying PSN stock? Here’s what analysts think:
